This detoxification process helps to protect the liver, improve overall health, and prevent various diseases
This injectable medication is classified as a Glucagon-Like Peptide 1 (GLP-1) receptor agonist, acting similarly to the hormone GLP-1
Liraglutide (Saxenda) another GLP-1 receptor agonist, recommended by NICE (TA664) for use in specialist weight management services under defined eligibility criteria, including BMI thresholds and the presence of weight-related comorbidities
Advances in patented CB1 receptor antagonists for obesity
doi: 10.2147/IMCRJ.S74563 [PubMed] 25873702 Janssen J, Singh-Saluja S
Theres no reason to stop a medication that is otherwise working well. Oral side effects on semaglutide, tirzepatide, and other GLP-1s occur often enough to be worth talking about